Oral glutathione (300 mg daily for four months) led to notable decreases in ALT, suggesting reduced liver inflammation
Clinical & Exp Metastasis
In a clinical environment, safety protocols are non-negotiable
(2015) randomized, double-blind, placebo-controlled trial showed that sustained daily supplementation with 1,000 mg of Setria oral glutathione increased blood glutathione levels by 30-35% over six months, with the 250 mg group also showing increases in whole blood
PubMed laboratory research record [PMID: 10869784] PubMed record related to this compound for laboratory literature review
In rat models, BPC-157 has been reported to accelerate tendon-to-bone healing and to reduce gastric ulcer surface area by as much as 78% in some experiments